3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Brain Neoplasms
2
Respiratory Tract Diseases
1
Neoplasms
1
Meningeal Carcinomatosis
1
Interventions
Pemetrexed
5
Topotecan
3
Dexamethasone
3
Bevacizumab
3
osimertinib
2
Vitamin B 12
2
Trastuzumab
2
Spinal Puncture
2
Radiotherapy
2
Methotrexate
2
Folic Acid
2
Cytarabine
2
Busulfan
2
trioctyl phosphine oxide
1
trastuzumab deruxtecan
1
tipifarnib
1
merphos
1
mafosfamide
1
immunotoxin LMB-7
1
epothilone B
1
avelumab
1
aflutinib
1
XL647
1
Transplantation, Autologous
1
Temozolomide
1
Rituximab
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Mental Status and Dementia Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningeal Carcinomatosis
×
AZD3759
×
Clear all
NCT02228369
2021-01-05
BLOOM
AstraZeneca
Phase 1
Completed
108 enrolled